Do asthmatic smokers benefit as much as non-smokers on budesonide/formoterol maintenance and reliever therapy? Results of an open label study

Onno C. P. van Schayck*, John Haughney, Michel Aubier, Olof Selroos, Tommy Ekstrom, Juliette Ostinelli, Roland Buhl

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)189-196
JournalRespiratory Medicine
Volume106
Issue number2
DOIs
Publication statusPublished - Feb 2012

Keywords

  • ACQ-5
  • Asthma
  • Budesonide/formoterol maintenance and reliever therapy
  • Propensity-matched controls
  • Smokers
  • Symbicort SMART

Cite this